| abstract |
The present disclosure relates to a compound of Formula (I): (I), or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein Ring A, and R 1 through R 4 are as defined herein, and methods of making and using the same. |